BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35292786)

  • 41. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
    Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
    [No Abstract]   [Full Text] [Related]  

  • 42. Paired box gene 8-peroxisome proliferator-activated receptor-gamma fusion protein and loss of phosphatase and tensin homolog synergistically cause thyroid hyperplasia in transgenic mice.
    Diallo-Krou E; Yu J; Colby LA; Inoki K; Wilkinson JE; Thomas DG; Giordano TJ; Koenig RJ
    Endocrinology; 2009 Nov; 150(11):5181-90. PubMed ID: 19797117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
    Walts AE; Mirocha JM; Bose S
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1749-56. PubMed ID: 25702102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
    Yoo SK; Lee S; Kim SJ; Jee HG; Kim BA; Cho H; Song YS; Cho SW; Won JK; Shin JY; Park do J; Kim JI; Lee KE; Park YJ; Seo JS
    PLoS Genet; 2016 Aug; 12(8):e1006239. PubMed ID: 27494611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC.
    Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC
    Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
    Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathologic study and clinical significance of Hürthle cell papillary thyroid carcinoma.
    Mai KT; Thomas J; Yazdi HM; Commons AS; Lamba M; Stinson AW
    Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):329-37. PubMed ID: 15536332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of HBME-1 and CD56 in follicular variant of papillary carcinoma in children: An immunohistochemical study and their diagnostic utility.
    Skaria PE; Ahmed AA; Yin H; Nicol K; Reid KJ; Singh V
    Pathol Res Pract; 2019 May; 215(5):880-884. PubMed ID: 30711197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Patterns of Distant Metastases in Follicular, Papillary and Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Horm Metab Res; 2022 Jan; 54(1):7-11. PubMed ID: 34758495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    Giani C; Torregrossa L; Ramone T; Romei C; Matrone A; Molinaro E; Agate L; Materazzi G; Piaggi P; Ugolini C; Basolo F; Ciampi R; Elisei R
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4072-e4083. PubMed ID: 34231847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus.
    Fridman MV; Savva NN; Krasko OV; Zborovskaya AA; Mankovskaya SV; Schmid KW; Demidchik YE
    Thyroid; 2012 Oct; 22(10):1016-24. PubMed ID: 22947350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.
    Liu J; Singh B; Tallini G; Carlson DL; Katabi N; Shaha A; Tuttle RM; Ghossein RA
    Cancer; 2006 Sep; 107(6):1255-64. PubMed ID: 16900519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.
    Ito Y; Miyauchi A
    Endocr J; 2009; 56(2):177-92. PubMed ID: 18703852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma.
    Cameron BR; Berean KW
    J Otolaryngol; 2003 Oct; 32(5):319-22. PubMed ID: 14974863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.
    Dobson ME; Diallo-Krou E; Grachtchouk V; Yu J; Colby LA; Wilkinson JE; Giordano TJ; Koenig RJ
    Endocrinology; 2011 Nov; 152(11):4455-65. PubMed ID: 21952241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.